Nov 12, 2025 08:02AM
Nov 12, 2025 08:00AM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Aug 12, 2025 05:46PM
Aug 12, 2025 04:10PM
May 14, 2025 09:00AM Cantor Fitzgerald Reiterates Overweight Rating on Astria Therapeutics (ATXS)
May 13, 2025 04:11PM
May 13, 2025 04:10PM
Mar 11, 2025 08:00AM
Nov 13, 2024 04:11PM
Nov 13, 2024 04:10PM
Aug 12, 2024 04:21PM
Aug 12, 2024 04:10PM Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
May 21, 2024 07:39AM
May 9, 2024 04:18PM
May 9, 2024 04:10PM
Mar 4, 2024 04:10PM
Nov 13, 2023 08:06AM
Nov 13, 2023 08:00AM
Oct 30, 2023 08:00AM Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th
Aug 7, 2023 05:12PM
Aug 7, 2023 04:10PM
May 11, 2023 05:55PM
May 11, 2023 04:10PM
Mar 22, 2023 08:20AM
Mar 22, 2023 08:00AM
Mar 8, 2023 08:00AM Astria Therapeutics to Report Fourth Quarter/Full Year 2022 Financial Results and Recent Corporate Developments on Wednesday, March 22nd
Nov 10, 2022 05:06PM
Nov 10, 2022 04:10PM
Aug 9, 2022 04:32PM
May 12, 2022 04:10PM
Mar 10, 2022 05:01PM
Nov 10, 2021 01:27PM
Nov 10, 2021 08:09AM Astria Therapeutics, Inc. (ATXS) Tops Q3 EPS by 16c; Reports Cash and Cash Equivalents of $131.8M
Nov 10, 2021 08:00AM
Oct 27, 2021 08:00AM

1,197,368 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All